Actavis' superbug antibiotic gets U.S. approval
February 25, 2015 at 17:28 PM EST
Feb 25 (Reuters) - The U.S Food and Drug Administration approved on Wednesday Actavis Plc's antibiotic to treat two infections caused by drug-resistant bacteria, or superbugs.
